URI
53
4
TGT
45
-2
NFLX
53
-2
FDX
37
-3
KMX
48
-2
AMGN
39
-2
AMG
30
-3
FMC
29
-5
FFIV
60
-2
EMC
18
-12
EA
30
-6
NEE
46
-3
MSFT
43
-3
BA
33
-2
DUK
67
-3
AMZN
50
-6
BAC
32
-4
APD
27
-3
NTRS
32
-12
CMS
65
-2
URI
53
4
TGT
45
-2
NFLX
53
-2
FDX
37
-3
KMX
48
-2
AMGN
39
-2
AMG
30
-3
FMC
29
-5
FFIV
60
-2
EMC
18
-12
EA
30
-6
NEE
46
-3
MSFT
43
-3
BA
33
-2
DUK
67
-3
AMZN
50
-6
BAC
32
-4
APD
27
-3
NTRS
32
-12
CMS
65
-2
Financhill
Back

Cassava Sciences 10K Form

Buy
60

SAVA
Cassava Sciences

Last Price:
26.92
Seasonality Move:
4.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12 10Q SAVA/Cassava Sciences Quarterly
2020-05-06 10Q SAVA/Cassava Sciences Quarterly
2020-03-26 10K SAVA/Cassava Sciences Annual
2019-10-29 10Q SAVA/Cassava Sciences Quarterly
2019-08-12 10Q SAVA/Cassava Sciences Quarterly
2019-05-02 10Q SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales: $41.12M
Cash Flow: $-18.27M
Price / Cash Flow: 0
Annual Sales: $3.94
Price / Book: 6.83

Profitability

EPS (TTM): -1.41000
Net Income (TTM): $-15.37M
Gross Margin: $20.56M
Return on Equity: 0%
Return on Assets: 0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
  • The Selling, General & Administrative Expenses for SAVA have been equal to 11.77% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 10 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SAVA
CUSIP: 14817C
Website: cassavasciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SAVA Technical Analysis vs Fundamental Analysis

Buy
60
Cassava Sciences (SAVA) is a Buy

Is Cassava Sciences a Buy or a Sell?

  • Cassava Sciences stock is rated a Buy
    The current Cassava Sciences [SAVA] share price is $26.91. The Score for SAVA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.